BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND LIFR, SJS2, 3977, ENSG00000113594, SWS, STWS, CD118
17 results:

  • 1. Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis.
    Di Giorgio C; Morretta E; Lupia A; Bellini R; Massa C; Urbani G; Bordoni M; Marchianò S; Lachi G; Rapacciuolo P; Finamore C; Sepe V; Chiara Monti M; Moraca F; Natalizi N; Graziosi L; Distrutti E; Biagioli M; Catalanotti B; Donini A; Zampella A; Fiorucci S
    Biochem Pharmacol; 2024 May; 223():116134. PubMed ID: 38494064
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification and validation of ferroptosis-related biomarkers and the related pathogenesis in precancerous lesions of gastric cancer.
    Kuang Y; Yang K; Meng L; Mao Y; Xu F; Liu H
    Sci Rep; 2023 Sep; 13(1):16074. PubMed ID: 37752199
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment.
    Fan Y; Li Y; Yao X; Jin J; Scott A; Liu B; Wang S; Huo L; Wang Y; Wang R; Pool Pizzi M; Ma L; Shao S; Sewastjanow-Silva M; Waters R; Chatterjee D; Liu B; Shanbhag N; Peng G; Calin GA; Mazur PK; Hanash SM; Ishizawa J; Hirata Y; Nagano O; Wang Z; Wang L; Xian W; McKeon F; Ajani JA; Song S
    Gut; 2023 Apr; 72(4):624-637. PubMed ID: 36002248
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Leukaemia inhibitory factor in gastric cancer: friend or foe?
    Seeneevassen L; Martin OCB; Lehours P; Dubus P; Varon C
    Gastric Cancer; 2022 Mar; 25(2):299-305. PubMed ID: 35106710
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Circ_0003159 upregulates lifr expression through competitively binding to miR-221-3p/miR-222-3p to block gastric cancer development.
    Zheng L; Yan B; Jin G; Han W; Wang H; Wang Z; Ma Y; Nian Y; Meng X; Jiang Z
    J Mol Histol; 2022 Apr; 53(2):173-186. PubMed ID: 35034206
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of lncRNA-associated competing endogenous RNA networks for occurrence and prognosis of gastric carcinoma.
    Ye L; Jin W
    J Clin Lab Anal; 2021 Dec; 35(12):e24028. PubMed ID: 34704289
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Second Primary Tumors in Patients with Gastrointestinal Stromal Tumors: A Single-Center Experience.
    Koçer M; Muallaoğlu S; Çetin B; Coşkun HŞ; Karahan N; Gürdal O
    Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34068309
    [No Abstract]    [Full Text] [Related]  

  • 8. Lidocaine Suppresses gastric cancer Development Through Circ_ANO5/miR-21-5p/lifr Axis.
    Guan E; Liu H; Xu N
    Dig Dis Sci; 2022 Jun; 67(6):2244-2256. PubMed ID: 34050852
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. lncRNA lifr‑AS1 inhibits gastric carcinoma cell proliferation, migration and invasion by sponging miR‑4698.
    Zhao J; Li X; Fu L; Zhang N; Yang J; Cai J
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355363
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the lifr-Hippo-YAP pathway.
    Bian SB; Yang Y; Liang WQ; Zhang KC; Chen L; Zhang ZT
    Ann N Y Acad Sci; 2021 Jan; 1484(1):74-89. PubMed ID: 32827446
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. High long non-coding lifr-AS1 expression correlates with poor survival in gastric carcinoma.
    Wang HF; Lv JQ; Li HH; Wang W; Lin FQ
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5378-5384. PubMed ID: 32495872
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. miR-589 promotes gastric cancer aggressiveness by a lifr-PI3K/AKT-c-Jun regulatory feedback loop.
    Zhang F; Li K; Pan M; Li W; Wu J; Li M; Zhao L; Wang H
    J Exp Clin Cancer Res; 2018 Jul; 37(1):152. PubMed ID: 30012200
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A novel long noncoding RNA-LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion.
    Zhao JH; Sun JX; Song YX; Chen XW; Yang YC; Ma B; Wang J; Gao P; Wang ZN
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):601-9. PubMed ID: 26537802
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A preliminary experience with minimally invasive Ivor Lewis esophagectomy.
    Tapias LF; Morse CR
    Dis Esophagus; 2012 Jul; 25(5):449-55. PubMed ID: 21967644
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Circadian distribution of sleep phases after major abdominal surgery.
    Gögenur I; Wildschiøtz G; Rosenberg J
    Br J Anaesth; 2008 Jan; 100(1):45-9. PubMed ID: 18037670
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Sequencing topotecan and etoposide plus cisplatin to overcome topoisomerase I and II resistance: a pharmacodynamically based Phase I trial.
    Aisner J; Musanti R; Beers S; Smith S; Locsin S; Rubin EH
    Clin Cancer Res; 2003 Jul; 9(7):2504-9. PubMed ID: 12855624
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Endoscopic-assisted intrathoracic oesophagogastrostomy without thoracotomy for tumours of the lower oesophagus and cardia.
    Sutton CD; White SA; Marshall LJ; Berry DP; Veitch PS
    Eur J Surg Oncol; 2002 Feb; 28(1):46-8. PubMed ID: 11869013
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.